| Date: |
11-04-2021
|
| Notification No: |
Notification No. 01/2015-2020
|
| Issuing Authority: |
DGFT
|
| Type: |
Notification
|
| File No: |
[F. No. 01/91/180/24/AM-22/EC/E-27724] |
| Subject: |
Amendment in Export Policy of Injection Remdesivir and Remdesivir API.
|
|
Government of India
Ministry Of Commerce And Industry
Department of Commerce
Directorate General Of Foreign Trade
Udyog Bhawan
New Delhi
Notification No. 01/2015-2020
New Delhi, Dated: 11th April, 2021
Subject : Amendment in Export Policy of Injection
Remdesivir and Remdesivir API.
S.O. 1548(E).—In exercise of powers conferred
by Section 3 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22
of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy,
2015-20, the Central Government hereby makes the following amendment in Schedule
2 of the ITCHS Export policy related to export of Injection Remdesivir and
Remdesivir Active Pharmaceutical Ingredients (API):
| S. No. |
ITC HS Codes |
Description |
Present Policy |
Revised Policy |
| 207AA |
Ex 293499
Ex 300490 |
Injection Remdesivir and Remdesivir
Active Pharmaceutical Ingredients(API) |
Free |
Prohibited |
2. The provision under Para 1.05 of the Foreign
Trade Policy (FTP) 2015-20 regarding transitional arrangement is not applicable
for this notification.
3. Effect of this Notification:
The export
of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API)
falling under the ITCHS Codes specified above or falling under any other HS Code
has been prohibited, with immediate effect.
[F. No. 01/91/180/24/AM-22/EC/E-27724]
AMIT
YADAV,
Director General of Foreign Trade
Ex-Officio Additional Secretary,Government of India
Email:[email protected]
|
|
|